These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 21600833)

  • 1. Gray matter volume deficits in spinocerebellar ataxia: an optimized voxel based morphometric study.
    Goel G; Pal PK; Ravishankar S; Venkatasubramanian G; Jayakumar PN; Krishna N; Purushottam M; Saini J; Faruq M; Mukherji M; Jain S
    Parkinsonism Relat Disord; 2011 Aug; 17(7):521-7. PubMed ID: 21600833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visualization, quantification and correlation of brain atrophy with clinical symptoms in spinocerebellar ataxia types 1, 3 and 6.
    Schulz JB; Borkert J; Wolf S; Schmitz-Hübsch T; Rakowicz M; Mariotti C; Schöls L; Timmann D; van de Warrenburg B; Dürr A; Pandolfo M; Kang JS; Mandly AG; Nägele T; Grisoli M; Boguslawska R; Bauer P; Klockgether T; Hauser TK
    Neuroimage; 2010 Jan; 49(1):158-68. PubMed ID: 19631275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain white matter damage in SCA1 and SCA2. An in vivo study using voxel-based morphometry, histogram analysis of mean diffusivity and tract-based spatial statistics.
    Della Nave R; Ginestroni A; Tessa C; Salvatore E; De Grandis D; Plasmati R; Salvi F; De Michele G; Dotti MT; Piacentini S; Mascalchi M
    Neuroimage; 2008 Oct; 43(1):10-9. PubMed ID: 18672073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociation of grey and white matter reduction in spinocerebellar ataxia type 3 and 6: a voxel-based morphometry study.
    Lukas C; Schöls L; Bellenberg B; Rüb U; Przuntek H; Schmid G; Köster O; Suchan B
    Neurosci Lett; 2006 Nov; 408(3):230-5. PubMed ID: 17005321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADC mapping of neurodegeneration in the brainstem and cerebellum of patients with progressive ataxias.
    Della Nave R; Foresti S; Tessa C; Moretti M; Ginestroni A; Gavazzi C; Guerrini L; Salvi F; Piacentini S; Mascalchi M
    Neuroimage; 2004 Jun; 22(2):698-705. PubMed ID: 15193598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6.
    Reetz K; Costa AS; Mirzazade S; Lehmann A; Juzek A; Rakowicz M; Boguslawska R; Schöls L; Linnemann C; Mariotti C; Grisoli M; Dürr A; van de Warrenburg BP; Timmann D; Pandolfo M; Bauer P; Jacobi H; Hauser TK; Klockgether T; Schulz JB;
    Brain; 2013 Mar; 136(Pt 3):905-17. PubMed ID: 23423669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain structural damage in spinocerebellar ataxia type 2. A voxel-based morphometry study.
    Della Nave R; Ginestroni A; Tessa C; Cosottini M; Giannelli M; Salvatore E; Sartucci F; De Michele G; Dotti MT; Piacentini S; Mascalchi M
    Mov Disord; 2008 Apr; 23(6):899-903. PubMed ID: 18311829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of fractional anisotropy changes in white matter of cerebellar peduncles distinguish spinocerebellar ataxia-1 from multiple system atrophy and other ataxia syndromes.
    Prakash N; Hageman N; Hua X; Toga AW; Perlman SL; Salamon N
    Neuroimage; 2009 Aug; 47 Suppl 2():T72-81. PubMed ID: 19446636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Spinocerebellar ataxias type 1 and 2: comparison of clinical, electrophysiological and magnetic resonance evaluation].
    Rakowicz M; Zdzienicka E; Poniatowska R; Waliniowska E; Sułek A; Jakubowska T; Niedzielska K; Rola R; Wierzbicka A; Hoffman-Zacharska D; Głazowski C; Jakubczyk T; Niewiadomska M; Zaremba J
    Neurol Neurochir Pol; 2005; 39(4):263-275. PubMed ID: 16096942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brainstem neurodegeneration correlates with clinical dysfunction in SCA1 but not in SCA2. A quantitative volumetric, diffusion and proton spectroscopy MR study.
    Guerrini L; Lolli F; Ginestroni A; Belli G; Della Nave R; Tessa C; Foresti S; Cosottini M; Piacentini S; Salvi F; Plasmati R; De Grandis D; Siciliano G; Filla A; Mascalchi M
    Brain; 2004 Aug; 127(Pt 8):1785-95. PubMed ID: 15240431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gray and white matter alterations in spinocerebellar ataxia type 7: an in vivo DTI and VBM study.
    Alcauter S; Barrios FA; Díaz R; Fernández-Ruiz J
    Neuroimage; 2011 Mar; 55(1):1-7. PubMed ID: 21147232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortical atrophy in the cerebellar variant of multiple system atrophy: a voxel-based morphometry study.
    Brenneis C; Boesch SM; Egger KE; Seppi K; Scherfler C; Schocke M; Wenning GK; Poewe W
    Mov Disord; 2006 Feb; 21(2):159-65. PubMed ID: 16161039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parahippocampal gray matter alterations in Spinocerebellar Ataxia Type 2 identified by voxel based morphometry.
    Mercadillo RE; Galvez V; Díaz R; Hernández-Castillo CR; Campos-Romo A; Boll MC; Pasaye EH; Fernandez-Ruiz J
    J Neurol Sci; 2014 Dec; 347(1-2):50-8. PubMed ID: 25263602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency analysis and clinical characterization of spinocerebellar ataxia types 1, 2, 3, 6, and 7 in Korean patients.
    Lee WY; Jin DK; Oh MR; Lee JE; Song SM; Lee EA; Kim GM; Chung JS; Lee KH
    Arch Neurol; 2003 Jun; 60(6):858-63. PubMed ID: 12810491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data.
    Jacobi H; Reetz K; du Montcel ST; Bauer P; Mariotti C; Nanetti L; Rakowicz M; Sulek A; Durr A; Charles P; Filla A; Antenora A; Schöls L; Schicks J; Infante J; Kang JS; Timmann D; Di Fabio R; Masciullo M; Baliko L; Melegh B; Boesch S; Bürk K; Peltz A; Schulz JB; Dufaure-Garé I; Klockgether T
    Lancet Neurol; 2013 Jul; 12(7):650-8. PubMed ID: 23707147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinocerebellar ataxia type 2 (SCA2) with white matter involvement.
    Armstrong J; Bonaventura I; Rojo A; González G; Corral J; Nadal N; Volpini V; Ferrer I
    Neurosci Lett; 2005 Jun; 381(3):247-51. PubMed ID: 15896478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autosomal dominant cerebellar ataxia: phenotypic differences in genetically defined subtypes?
    Schöls L; Amoiridis G; Büttner T; Przuntek H; Epplen JT; Riess O
    Ann Neurol; 1997 Dec; 42(6):924-32. PubMed ID: 9403486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinocerebellar ataxia type 1 (SCA1): new pathoanatomical and clinico-pathological insights.
    Rüb U; Bürk K; Timmann D; den Dunnen W; Seidel K; Farrag K; Brunt E; Heinsen H; Egensperger R; Bornemann A; Schwarzacher S; Korf HW; Schöls L; Bohl J; Deller T
    Neuropathol Appl Neurobiol; 2012 Dec; 38(7):665-80. PubMed ID: 22309224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [CAG trinucleotide mutation detection in patients with hereditary spinocerebellar ataxia].
    Tang B; Xia J; Wang D; Tang X; Shen L; Liu C; Dai H; Yan X; Pan Q; Xiao J; Zhang B; Ou Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Oct; 16(5):281-4. PubMed ID: 10514531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms.
    Schmitz-Hübsch T; Coudert M; Bauer P; Giunti P; Globas C; Baliko L; Filla A; Mariotti C; Rakowicz M; Charles P; Ribai P; Szymanski S; Infante J; van de Warrenburg BP; Dürr A; Timmann D; Boesch S; Fancellu R; Rola R; Depondt C; Schöls L; Zdienicka E; Kang JS; Döhlinger S; Kremer B; Stephenson DA; Melegh B; Pandolfo M; di Donato S; du Montcel ST; Klockgether T
    Neurology; 2008 Sep; 71(13):982-9. PubMed ID: 18685131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.